ReleaseWire Connect

CorAssist Cardiovascular Ltd. (CorAssist) is a medical device company, based in Israel. It develops and manufactures innovative therapeutic products for the cardiovascular market. The company develops products such as invasive medical devices and intraventricular devices that are used in the treatment of diastolic heart failure. Its product portfolio includes ImCardia, ImCardia MIS and Aurora. CorAssist develops elastic and self-expanding devices, which operate by transferring energy harnessed during systole to the left ventricle during diastole for improved diastolic performance. It utilizes its patented technology for the implantation of the devices that improves cardiac diastolic function. CorAssist is headquartered in Hezliya Pitauch, Israel.

Sports nutrition sales grew by 1% in 2011. Rising health consciousness and a boom in running helped push category growth, aided by manufacturers continuously launching new products. Running is a foundation of many sports, and helps build up an individual's physical strength. According to a study by the Japan Productivity Centre, the number of people who enjoy running and jogging has risen to approximately 28 million people. One of the key running events, the Tokyo Marathon,

This report provides readers with a comprehensive analysis of the Naval Vessels and Surface Combatantsmarket through 2011-2021, including highlights of the demand drivers and growth stimulators for Naval Vessels and Surface Combatants. It also provides an insight on the spending pattern and modernization pattern in different regions around the world.

GlobalData's clinical trial report, "Aortic Aneurysm Global Clinical Trials Review, H1, 2012" provides data on the Aortic Aneurysm clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Aortic Aneurysm. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Aortic Aneurysm. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Value sales of calming and sleeping declined by 4% in 2011, because the market has reached saturation. Sales grew quickly by a CAGR of 31% between 2003 and 2009, with SSP Co Ltd's launch of Drewell, which was the first OTC medicine to include the active ingredient diphenhydramine hydrochloride. In 2007, other manufacturers entered the market to take advantage of its rapid growth. Taisho Pharmaceutical Co Ltd launched Neody and Resty, while GlaxoSmithKline KK introduced Nytol.

Businesses in the Auto Part Manufacturing industry in China produce parts, accessories and components for motor vehicles, including motor vehicle bodies, mechanical and electronic components, and parts for electric motors. These manufacturers supply motor vehicle assembly and replacement part companies (i.e. the aftermarket).

During a period of restricted discretionary spend and low consumer confidence, it is imperative that retailers know who their core customer base is and how they should be targeting them. UK Customer Insights 2012 are based around individual retailers and provide a highly detailed, data-rich overview of a retailer's customers, including shopper profiles and the drivers of loyalty and disloyalty.

Despite the fact that economic indicators showed positive results in the last few years, the general feel of the Israeli public is that the cost of living is too high. During 2011 the Israeli middle-classes spoke up for the first time in many years against what is referred to as "social injustice". An atmosphere of civil activism was spreading across Israel within a wide range of economic and social topics, as Israelis from all over the country were protesting their civil and social rights.

This analysis evaluates the company's strategy and key strengths, weaknesses, opportunities and threats, and provides an overview of the company's historical and forecast financial performance. The report also gives an in-depth analysis of the company's key prescription pharmaceutical product, and provides a forecast sales performance for this drug.

Innovation in cereal products continues to evolve in line with changing consumer needs. This report outlines important consumer and product trends impacting this category globally, based on Datamonitor's TrendSights mega-trend framework to classify the key themes. Breakfast cereals and cereal bars are covered to provide a complete picture of the trends driving innovation in this category.